Source:http://linkedlifedata.com/resource/pubmed/id/14676987
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2004-2-10
|
pubmed:abstractText |
Several cases of death associated with 4-methylthioamphetamine (4-MTA) have raised public concern about the abuse of this designer drug that is usually sold as "Ecstasy" or "Flatliners". Since only very little is known about the metabolism of 4-MTA in humans we performed an in vitro study incubating racemic 4-MTA with primary hepatocytes isolated from three male human donors. Additionally, hepatocytes from male monkey (Cynomolgus), dog (Beagle), rabbit (Chinchilla), rat (Sprague-Dawley), and mouse (CD1) were examined for the metabolism of racemic 4-MTA. We observed that 4-MTA was not extensively metabolised by hepatocytes from all species examined. The main metabolite was identified as 4-methylthiobenzoic acid which, for the first time has been described as a human metabolite. In addition to metabolism we also examined 4-MTA-induced toxicity as evidenced by the ATP cellular content. Interestingly, one of the three human donors showed a dramatically increased sensitivity to the reduction in ATP content induced by 4-MTA. Comparing the species examined, the most extensive formation of 4-methylthiobenzoic acid was observed in the rabbit hepatocytes followed by human, monkey, dog and mouse hepatocytes, whereas no formation of 4-methylthiobenzoic acid was seen in the rat hepatocytes. Toxicity data suggest that rabbit hepatocytes are more resistant to 4-MTA than the other species, which may be due to the more extensive metabolism. In conclusion, we have shown that 4-methylthiobenzoic acid is the main metabolite formed from 4-MTA by human hepatocytes and also by the hepatocytes of the other tested species except the rat. Toxicity data suggest only moderate interspecies differences.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/4-methylthioamphetamine,
http://linkedlifedata.com/resource/pubmed/chemical/4-methylthiobenzoic acid,
http://linkedlifedata.com/resource/pubmed/chemical/Amphetamines,
http://linkedlifedata.com/resource/pubmed/chemical/Benzoic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Central Nervous System Stimulants
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0028-1298
|
pubmed:author |
pubmed-author:CarmoHelenaH,
pubmed-author:CarvalhoFélixF,
pubmed-author:FernandesEduardaE,
pubmed-author:HengstlerJan GJG,
pubmed-author:OeschFranzF,
pubmed-author:RemiãoFernandoF,
pubmed-author:RingelMichaelM,
pubmed-author:de BoerDouweD,
pubmed-author:de Lourdes BastosMariaM,
pubmed-author:dos ReysLesseps ALA
|
pubmed:issnType |
Print
|
pubmed:volume |
369
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
198-205
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14676987-Amphetamines,
pubmed-meshheading:14676987-Animals,
pubmed-meshheading:14676987-Benzoic Acids,
pubmed-meshheading:14676987-Central Nervous System Stimulants,
pubmed-meshheading:14676987-Dogs,
pubmed-meshheading:14676987-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:14676987-Hepatocytes,
pubmed-meshheading:14676987-Humans,
pubmed-meshheading:14676987-Macaca fascicularis,
pubmed-meshheading:14676987-Male,
pubmed-meshheading:14676987-Mice,
pubmed-meshheading:14676987-Middle Aged,
pubmed-meshheading:14676987-Rabbits,
pubmed-meshheading:14676987-Rats,
pubmed-meshheading:14676987-Rats, Sprague-Dawley,
pubmed-meshheading:14676987-Species Specificity,
pubmed-meshheading:14676987-Time Factors
|
pubmed:year |
2004
|
pubmed:articleTitle |
Comparative metabolism of the designer drug 4-methylthioamphetamine by hepatocytes from man, monkey, dog, rabbit, rat and mouse.
|
pubmed:affiliation |
REQUIMTE, Toxicology Department, Faculty of Pharmacy, Porto University, Rua Aníbal Cunha 164, 4050-047 Porto, Portugal. helenacarmo@ff.up.pt
|
pubmed:publicationType |
Journal Article,
Comparative Study,
In Vitro,
Research Support, Non-U.S. Gov't
|